BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 21956718)

  • 1. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
    Ito D; Suzuki N
    Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration.
    Zhao B; Cowan CM; Coutts JA; Christy DD; Saraph A; Hsueh SCC; Plotkin SS; Mackenzie IR; Kaplan JM; Cashman NR
    Acta Neuropathol Commun; 2023 Dec; 11(1):200. PubMed ID: 38111057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.
    Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS.
    Motaln H; Čerček U; Yamoah A; Tripathi P; Aronica E; Goswami A; Rogelj B
    Brain; 2023 Oct; 146(10):4088-4104. PubMed ID: 37071594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules.
    Vance C; Scotter EL; Nishimura AL; Troakes C; Mitchell JC; Kathe C; Urwin H; Manser C; Miller CC; Hortobágyi T; Dragunow M; Rogelj B; Shaw CE
    Hum Mol Genet; 2013 Jul; 22(13):2676-88. PubMed ID: 23474818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility.
    Gleixner AM; Verdone BM; Otte CG; Anderson EN; Ramesh N; Shapiro OR; Gale JR; Mauna JC; Mann JR; Copley KE; Daley EL; Ortega JA; Cicardi ME; Kiskinis E; Kofler J; Pandey UB; Trotti D; Donnelly CJ
    Nat Commun; 2022 Jun; 13(1):3380. PubMed ID: 35697676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALS/FTLD-Linked Mutations in FUS Glycine Residues Cause Accelerated Gelation and Reduced Interactions with Wild-Type FUS.
    Rhine K; Makurath MA; Liu J; Skanchy S; Lopez C; Catalan KF; Ma Y; Fare CM; Shorter J; Ha T; Chemla YR; Myong S
    Mol Cell; 2020 Nov; 80(4):666-681.e8. PubMed ID: 33159856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum.
    Van Langenhove T; van der Zee J; Van Broeckhoven C
    Ann Med; 2012 Dec; 44(8):817-28. PubMed ID: 22420316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1.
    Ederle H; Funk C; Abou-Ajram C; Hutten S; Funk EBE; Kehlenbach RH; Bailer SM; Dormann D
    Sci Rep; 2018 May; 8(1):7084. PubMed ID: 29728564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUS ALS neurons activate major stress pathways and reduce translation as an early protective mechanism against neurodegeneration.
    Szewczyk B; Günther R; Japtok J; Frech MJ; Naumann M; Lee HO; Hermann A
    Cell Rep; 2023 Feb; 42(2):112025. PubMed ID: 36696267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
    Vance C; Rogelj B; Hortobágyi T; De Vos KJ; Nishimura AL; Sreedharan J; Hu X; Smith B; Ruddy D; Wright P; Ganesalingam J; Williams KL; Tripathi V; Al-Saraj S; Al-Chalabi A; Leigh PN; Blair IP; Nicholson G; de Belleroche J; Gallo JM; Miller CC; Shaw CE
    Science; 2009 Feb; 323(5918):1208-1211. PubMed ID: 19251628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD.
    Nag N; Tripathi T
    ACS Chem Neurosci; 2022 Sep; 13(17):2544-2546. PubMed ID: 36001801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish.
    Yu Y; Chi B; Xia W; Gangopadhyay J; Yamazaki T; Winkelbauer-Hurt ME; Yin S; Eliasse Y; Adams E; Shaw CE; Reed R
    Nucleic Acids Res; 2015 Mar; 43(6):3208-18. PubMed ID: 25735748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD.
    Tamaki Y; Urushitani M
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metals in ALS TDP-43 Pathology.
    Koski L; Ronnevi C; Berntsson E; Wärmländer SKTS; Roos PM
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
    Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
    J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.
    Kent L; Vizard TN; Smith BN; Topp SD; Vance C; Gkazi A; Miller J; Shaw CE; Talbot K
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):557-62. PubMed ID: 24899262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention.
    Humphrey J; Birsa N; Milioto C; McLaughlin M; Ule AM; Robaldo D; Eberle AB; Kräuchi R; Bentham M; Brown AL; Jarvis S; Bodo C; Garone MG; Devoy A; Soraru G; Rosa A; Bozzoni I; Fisher EMC; Mühlemann O; Schiavo G; Ruepp MD; Isaacs AM; Plagnol V; Fratta P
    Nucleic Acids Res; 2020 Jul; 48(12):6889-6905. PubMed ID: 32479602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo analysis of aggregation propensity of low levels of mislocalized TDP-43 on cytopathological and behavioral phenotype of ALS/FTLD.
    Wada H; Hikiami R; Kusui M; Minamiyama S; Asada-Utsugi M; Shodai A; Muramatsu SI; Morimura T; Urushitani M
    Neurosci Res; 2023 Aug; 193():41-51. PubMed ID: 36804599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of physiological biomolecular condensates in amyotrophic lateral sclerosis.
    Fakim H; Vande Velde C
    Semin Cell Dev Biol; 2024 Mar; 156():176-189. PubMed ID: 37268555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.